Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI
Multiparametric MRI
PET-CT
DOI:
10.1007/s00259-020-05140-y
Publication Date:
2020-12-20T00:07:43Z
AUTHORS (24)
ABSTRACT
Abstract Purpose Risk classification of primary prostate cancer in clinical routine is mainly based on prostate-specific antigen (PSA) levels, Gleason scores from biopsy samples, and tumor-nodes-metastasis (TNM) staging. This study aimed to investigate the diagnostic performance positron emission tomography/magnetic resonance imaging (PET/MRI) vivo models for predicting low-vs-high lesion risk (LH) as well biochemical recurrence (BCR) overall patient (OPR) with machine learning. Methods Fifty-two patients who underwent multi-parametric dual-tracer [ 18 F]FMC 68 Ga]Ga-PSMA-11 PET/MRI radical prostatectomy between 2014 2015 were included part a single-center pilot randomized prospective trial (NCT02659527). Radiomics combination ensemble learning was applied including PET, apparent diffusion coefficient, transverse relaxation time-weighted MRI scans each establish prediction model (M LH ). Furthermore, M BCR OPR predictive schemes built by combining , PSA, stage values patients. Performance evaluation established performed 1000-fold Monte Carlo (MC) cross-validation. Results additionally compared conventional standardized uptake value (SUV) analyses. The area under receiver operator characteristic curve (AUC) (0.86) higher than AUC SUV max analysis (0.80). MC cross-validation revealed 89% 91% accuracies 0.90 0.94 AUCs respectively, while standard score, TNM staging resulted 69% 70% predict respectively. Conclusion Our results demonstrate potential enhance radiomics without sampling.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (43)
CITATIONS (100)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....